Rishab Ramapriyan

6PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biomedical engineering not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 27, 2025
Reimagining Oncologic Drugs in Atherosclerosis: Emerging Mechanisms and Therapeutic Potential.

George Liu, Guillaume De Vlaminck, Osayamen Atekha

|Jul 12, 2025
A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant Glioma.

Masih Tazhibi, Eric P Grewal, Rishab Ramapriyan

|Jul 23, 2024
Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma.

Eric P Grewal, Leland G K Richardson, Jing Sun

|Nov 21, 2023
The Role of Antibody-Based Therapies in Neuro-Oncology.

Rishab Ramapriyan, Jing Sun, Annabel Curry

|Oct 09, 2020
Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapy.

Maria Angelica Cortez, Fatemeh Masrorpour, Cristina Ivan

|Sep 25, 2020
Bone morphogenetic protein 7 promotes resistance to immunotherapy.

Maria Angelica Cortez, Fatemeh Masrorpour, Cristina Ivan

Pageof 1